Metronidazole

甲硝唑

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameMetronidazole
Drug Alias Name甲硝哒唑甲硝基羟乙唑甲嘧唑乙醇美曲硝唑咪唑尼达 +[26
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSusceptible anaerobic bacteria infectionLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infections +[45
Global Approved IndicationsSusceptible anaerobic bacteria infectionLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infections +[14
Approved Indications in ChinaSusceptible anaerobic bacteria infectionLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infections +[14
Original Approved Country/TerritoryFrance
Original Approved Date1960/01/01
Country/TerritoryCanadaUnited StatesTurkey +[9
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active IndicationsSusceptible anaerobic bacteria infectionLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infections +[28
Inactive IndicationsVaginitisGenital Diseases, FemaleMeningitis +[17

Other Information

ATC CodeA01AB17D06BX01G01AF01 +[5